冈比亚麻疹第二剂疫苗覆盖率的影响因素——2019年人口与健康调查数据的二次分析
该研究对2019年冈比亚人口与健康调查中18-35月龄儿童(n=1010)进行二次分析,采用多变量logistic回归评估麻疹第二剂疫苗(MCV2)接种的影响因素。MCV2覆盖率为67.7%,婴儿期完成推荐疫苗程序与MCV2接种强相关(aOR 7.75,95%CI 3.98-15.12),城市女童接种 odds 低于男童(aOR 0.49,95%CI 0.31-0.78)。作者认为覆盖率仍低于消除阈值,干预应聚焦强化早期免疫、应对性别与城乡差异并促进2岁前及时接种。
要点
- MCV2覆盖率为67.7%,低于世界卫生组织推荐的≥95%消除阈值。
- 婴儿期完成推荐疫苗程序与MCV2接种强相关(aOR 7.75,95%CI 3.98-15.12)。
- 城市女童接种 odds 低于男童(aOR 0.49,95%CI 0.31-0.78),农村无显著差异(aOR 0.92,95%CI 0.60-1.39)。
核心结论
- 冈比亚MCV2覆盖率仍低于消除阈值,干预应聚焦强化早期免疫、应对性别与城乡差异并鼓励2岁前及时接种。
- 作者认为这些发现凸显冈比亚及类似环境需制定情境特异性策略以缩小免疫差距。
研究设计与样本
- 对2019年冈比亚人口与健康调查数据进行二次分析,纳入18-35月龄儿童(n=1010)。
- 采用多变量logistic回归评估MCV2接种状态与儿童、照护者及家庭层面因素之间的关联及因素间交互作用。
主要发现
- MCV2覆盖率为67.7%。
- 婴儿期完成推荐疫苗程序与MCV2接种强相关(aOR 7.75,95%CI 3.98-15.12)。
- 城市女童接种 odds 约为城市男童的一半(aOR 0.49,95%CI 0.31-0.78),农村地区未见显著差异(aOR 0.92,95%CI 0.60-1.39)。
- 性别修饰年龄与接种状态的关联:18-23月龄女童接种 odds 低于同年龄男童(aOR 0.41,95%CI 0.23-0.76),24-35月龄组差异不显著(aOR 0.73,95%CI 0.46-1.16)。
关键数值与推荐
- 世界卫生组织推荐含麻疹成分疫苗两剂次覆盖率≥95%以实现消除。
- 本研究MCV2覆盖率为67.7%,低于上述消除阈值。
临床怎么用
- 作者建议干预应聚焦强化早期免疫、应对性别与城乡差异并鼓励2岁前及时接种。
- 作者认为需制定情境特异性策略以缩小冈比亚及类似环境的免疫差距。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Measles remains a leading cause of vaccine-preventable mortality in Africa, despite the availability of safe and effective vaccines. The World Health Organization recommends ≥95 % coverage with two doses of a measles-containing vaccine (MCV) to achieve elimination. In The Gambia, coverage with the second dose of measles containing vaccine (MCV2) remains below this target. Understanding the factors associated with sub-optimal MCV2 coverage in The Gambia is crucial for developing strategies to improve vaccine coverage. METHODS: We conducted a secondary analysis of data from the 2019 Gambia Demographic and Health Survey to identify determinants of MCV2 vaccination among children aged 18-35 months (n = 1010). Multivariable logistic regression was used to assess associations between MCV2 vaccination status and child-, caregiver-, and household-level factors and interactions between these factors. RESULTS: MCV2 coverage was 67.7 %. In multivariable analysis, completion of the recommended infant vaccine schedule in the first year of life was strongly associated with MCV2 uptake (adjusted odds ratio [aOR]: 7.75; 95 % CI: 3.98-15.12). Female children in urban areas had half the odds of vaccination compared to male children (aOR: 0.49; 95 % CI 0.31-0.78); while no significant difference was observed in rural areas (aOR: 0.92; 95 % CI; 0.60-1.39). Sex also modified the association between age and vaccination status. Among children aged 18-23 months, females had lower odds of vaccination compared to similarly aged males (aOR: 0.41; 95 % CI: 0.23-0.76) but the difference was not significant among children aged 24-35 months (aOR: 0.73; 95 % CI: 0.46-1.16). CONCLUSION: MCV2 coverage in The Gambia remains below the elimination threshold. Interventions should focus on strengthening early-life immunization, addressing gender and urban-rural disparities, and encouraging timely vaccination before 2 years of age. These findings highlight the need for context-specific strategies to close immunization gaps in The Gambia and similar settings.
引用
- Bruce AA, Gallagher K. Determinants of measles second-dose vaccine coverage in the Gambia - a secondary analysis of 2019 demographic and health survey data. Vaccine. 2025. PMID: 41046835. doi:10.1016/j.vaccine.2025.127789
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。